Short-Term Risk of HIV-Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral Therapy

Simple item page
dc.contributor.authorCharlebois, Edwin D
dc.contributor.authorRuel, Theodore D
dc.contributor.authorGasasira, Anne F.
dc.contributor.authorAchan, Jane
dc.contributor.authorKateera, Frederick
dc.contributor.authorAkello, Caroline
dc.contributor.authorCao, Huyen
dc.contributor.authorDorsey, Grant
dc.contributor.authorRosenthal, Philip J
dc.contributor.authorSsewanyana, Isaac
dc.contributor.authorKamya, Moses R
dc.contributor.authorHavlir, Diane V
dc.date.accessioned2021-12-13T07:48:55Z
dc.date.available2021-12-13T07:48:55Z
dc.date.issued2010
dc.description.abstractBackground—Increasing numbers of HIV-infected children not yet eligible for antiretroviral therapy (ART) are entering health care in Africa. We sought to characterize the risk of short-term disease progression in this population. Methods—In a cohort of HIV-infected ART-naive and -ineligible Ugandan children >1 year old, the rates of clinical/immunologic progression within 2 years were assessed using Kaplan–Meier survival analysis and multivariate Cox proportional-hazards modeling. Results—Among 192 children (mean age: 6.4 years, CD4%:25), 19% progressed within 2 years by WHO-stage 3/4 event(n=22), death (n=3), or WHO-defined CD4 threshold for ARTinitiation( n=12). Significant univariate predictors were CD4%(HR=2.0 per 10% decrease, p=0.005), HIV-RNA level(HR=2.4 per log10 increase, p=0.002), male gender (HR:2.0, p=0.04), age < 3 years (HR=3.7, p=0.001), CD4-activation [%CD4+CD38+HLADR+] (HR=1.6 per 10% increase, p=0.05) and CD8-activation [%CD8+CD38+HLADR+](HR=1.3 per 10% increase, p=0.05] (HR=1.3, p=0.5). In multivariate analysis, CD4%(HR=2.0, p=0.034), HIV-RNA level(HR=1.8, p=0.013) and age < 3 years (HR:3.0, p=0.008) were independently predictive. Children with HIV-RNA >105 copies/ml and CD4% <25 had progression rates of 29% (1 year) and 34% (2 years). Conclusions—Even with frequent CD4 monitoring, HIV-infected Ugandan children experienced significant clinical events while ineligible for ART. Alternate strategies for monitoring or ART-initiation may be needed to improve outcomesen_US
dc.identifier.citationCharlebois, E. D., Ruel, T. D., Gasasira, A. F., Achan, J., Kateera, F., Akello, C., ... & Havlir, D. V. (2010). Short-Term Risk of HIV-Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral Therapy. Journal of acquired immune deficiency syndromes (1999), 55(3), 330.doi:10.1097/QAI.0b013e3181e583da.en_US
dc.identifier.other10.1097/QAI.0b013e3181e583da.
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/387
dc.language.isoenen_US
dc.publisherJournal of acquired immune deficiency syndromesen_US
dc.subjectHIVen_US
dc.subjectChildrenen_US
dc.subjectProgressionen_US
dc.subjectMonitoringen_US
dc.subjectResource-limiteden_US
dc.titleShort-Term Risk of HIV-Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral Therapyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Short-Term Risk of HIV-Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral Therapy.pdf
Size:
352.22 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences